Literature DB >> 17384083

Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide.

William J Perkins1, Miwa Taniguchi, David O Warner, Eduardo N Chini, Keith A Jones.   

Abstract

In a newly characterized cultured porcine pulmonary artery (PA) preparation, 24-h treatment with the nitric oxide (NO) donor (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO) decreased the response to acutely applied DETA-NO compared with 24-h control (-log EC(50) 6.55 +/- 0.12 and 5.02 +/- 0.21, respectively). Treatment of PA with the cell-permeable superoxide dismutase mimetic, Mn(III) tetra(4-benzoic acid) porphyrin chloride, did not change NO responsiveness in either freshly prepared or 24-h DETA-NO-treated PA. cGMP and cAMP phosphodiesterase activities were approximately equal in PA. Twenty-four-hour DETA-NO treatment did not change either cGMP or cAMP phosphodiesterase activities. Twenty-four hours in culture had no significant effect on soluble guanylyl cyclase (sGC) subunit mRNA expression, but 24-h DETA-NO treatment significantly decreased the expression of both sGCalpha(1) and sGCbeta(1). sGCbeta(1) protein expression was 42 +/- 4 ng/mg soluble protein. Twenty-four hours in culture without and with DETA-NO reduced sGCbeta(1) protein expression (36 +/- 3 and 31 +/- 3 ng/mg soluble protein, respectively, P < 0.025). Basal tissue cGMP [(cGMP)(i)] was significantly increased, and NO-induced (cGMP)(i) was significantly decreased by 24-h DETA-NO treatment. (cGMP)(i) normalized to the amount of sGC protein expressed in PA was significantly lower in PA treated for 24 h with DETA-NO compared with both freshly isolated and 24-h cultured PA. We conclude that prolonged NO treatment induces decreased acute NO responsiveness in part by decreasing both sGC expression and sGC-specific activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384083     DOI: 10.1152/ajplung.00368.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  5 in total

1.  Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.

Authors:  Nazish Sayed; Padmamalini Baskaran; Xiaolei Ma; Focco van den Akker; Annie Beuve
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

2.  Decrease of guanylyl cyclase β1 subunit and nitric oxide (NO)-induced relaxation in mouse rectum with colitis and its reproduction on long-term NO treatment.

Authors:  Yuri Hamada; Erina Kato; Hiroyuki Nakamura; Hiromichi Fujino; Kenjiro Matsumoto; Kimihito Tashima; Shunji Horie; Toshihiko Murayama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

3.  Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery.

Authors:  Huijuan Ma; Qiong He; Dou Dou; Xiaoxu Zheng; Lei Ying; Yuming Wu; J Usha Raj; Yuansheng Gao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-23       Impact factor: 5.464

4.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

5.  Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.

Authors:  William J Perkins; Susan Kost; Mark Danielson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.